Form EFFECT Nasus Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 31, 2026 |
| Accession Number: | 0001493152-26-013287 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Breakout Wellness UK Empowers the Next Generation of Wellness Innovators
- SATO Corporation Half-Year Report 1 January–30 June 2026: SATO’s steady development continued
- KuCoin Web3 Wallet Supports Robinhood Chain, Broadening Access to Tokenized Real-World Asset Ecosystems
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
